2021 CABA Annual Conference 2021美中生物医药协会年会

November 12, 2021

2021 CABA Annual Conference: New Era, New Horizon - Explore with Industry Pioneers and Leaders on the New Frontiers in Healthcare Innovation

2021美中生物医药协会年会: 新时代,新天际 - 与行业先驱和领袖一起探索医疗健康创新的新前沿

This year’s annual conference of CABA will host a collection of industry pioneers and leaders from a diverse background in science and business. These speakers will share exciting stories and developments and offer their insights in fields that will continue to improve human health, including RNA therapeutics, cell therapies, gene editing, and new materials and methods in life sciences. We hope you will join us and explore the new frontiers in healthcare innovation.

今年美中生物医药协会 CABA 年会有幸邀请到生命科学科技与商业方面的众位行业先驱与领袖。他们将分享各自领域的进展与洞见,包括RNA疗法,细胞疗法,基因编辑,以及生命科学方面的新材料与新方法 – 这些领域无疑将继续改善人类健康。我们诚邀您加入本次年会,一起探索医疗健康创新的新前沿。

Distinguished Speakers

Ke Xu, PhD
Founder, Chairman and CEO
VesiCURE

Eric von Hofe, PhD
President and COO
AffyImmune Therapeutics

Frank Neumann, MD, PhD
SVP and Global Head of Clinical Development
Kite Pharma

Bo Ying, PhD
Founder and CEO
Abogen Biosciences

Shi-Jiang (John) Lu, PhD, MPH
President and CEO
HebeCell Corporation

Don Haut, PhD
CEO
Carmine Therapeutics

Ed Zhang, MBA
Co-founder and Interim CEO
Overland Pharmaceuticals Venture Partner Hillhouse Capital

David Lebwohl, PhD
EVP and CMO
Intellia Therapeutics

Tasuku Kitada, PhD
President and Head of R&D
Strand Therapeutics

Vurtual Meeting

线上会议

12/04/2021

*注册即将开放